Washington Trust Advisors, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Washington Trust Advisors, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$9,138
+5.2%
1020.0%0.00%0.0%
Q2 2023$8,685
+2.9%
1020.0%0.00%0.0%
Q1 2023$8,441
+17.9%
102
+12.1%
0.00%0.0%
Q4 2022$7,157
+2.2%
910.0%0.00%0.0%
Q3 2022$7,000
+16.7%
910.0%0.00%0.0%
Q2 2022$6,0000.0%910.0%0.00%
Q1 2022$6,000
+20.0%
910.0%0.00%
Q4 2021$5,000910.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders